体外受精市場- 世界の産業規模、動向、機会、予測、技術別、製品別、卵子ドナー別、不妊症別、用途別、地域別セグメント、競合、2020年～2030年

世界の体外受精市場は、2024年に284億1,000万米ドルと評価され、2030年には408億7,000万米ドルに達すると予測され、予測期間中のCAGRは6.25％で成長します。

市場成長の原動力は、不妊率の上昇、生殖補助医療における技術進歩、子育て遅延の増加傾向にあります。体外受精生殖補助医療（ART）として広く採用されている体外受精（IVF）は、体外で精子と卵子を受精させ、胚を子宮に移植するものです。IVFは世界中で何百万人もの不妊症の克服に役立っています。人口の高齢化、ライフスタイルの変化、環境ストレスなどの要因が不妊症の増加に寄与しており、ARTソリューションの需要を押し上げています。さらに、改良された胚培養システムや個別化されたプロトコールなど、体外受精手順の進歩が成功率を高めています。また、政府の支援策、ヘルスケアへのアクセス拡大、一般市民の意識の高まりにより、体外受精がより身近なものとなっており、特に新興国では中間層の増加と保険適用が市場導入をさらに促進しています。

市場促進要因

世界の不妊率の上昇

主な市場課題

高い治療費と限られたアクセス性

主要市場動向

妊孕性温存の受け入れ拡大

目次

第1章 概要

• 市場の定義
• 市場の範囲
  • 対象市場
  • 調査対象年
  • 主要市場セグメンテーション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の体外受精市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 技術別（ICSI IVF、非ICSI/従来のIVF）
  • 製品別（体外受精培養液、顕微授精装置、体外受精インキュベーター、凍結システム、その他）
  • 卵子提供者別（凍結非提供者、新鮮非提供者、凍結提供者、新鮮提供者）
  • 不妊症別（男性、女性）
  • 用途別（不妊治療クリニック、病院、その他）
  • 地域別
  • 企業別（2024）
• 製品マップ

第6章 北米の体外受精市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の体外受精市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の体外受精市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の体外受精市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの体外受精市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界の体外受精市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• The Fertility Center of Las Vegas
• Overlake Reproductive Health
• Gennet City Fertility
• Zita West Clinic
• Fertility Plus Clinic
• Nova IVF Centre and Fertility Clinic
• Bloom IVF Centre
• Progenesis Fertility Center
• Medicana IVF Center
• Medical Park Hospitals
• ART Fertility Clinics

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global In-Vitro Fertilization Market was valued at USD 28.41 billion in 2024 and is projected to reach USD 40.87 billion by 2030, growing at a CAGR of 6.25% during the forecast period. Market growth is driven by rising infertility rates, technological advancements in assisted reproduction, and the increasing trend of delayed parenthood. In-vitro fertilization (IVF), a widely adopted assisted reproductive technology (ART), involves fertilizing an egg with sperm outside the body and transferring the embryo to the uterus. IVF has helped millions worldwide overcome infertility. Factors such as aging populations, lifestyle changes, and environmental stressors are contributing to rising infertility, pushing demand for ART solutions. Furthermore, advancements in IVF procedures-like improved embryo culture systems and personalized protocols-have increased success rates. Supportive government initiatives, expanded healthcare access, and growing public awareness are also making IVF more accessible, particularly in emerging economies, where a growing middle class and insurance coverage are further driving market adoption.

Key Market Drivers

Rising Infertility Rates Globally

The increasing global prevalence of infertility is a primary driver of the IVF market. According to the World Health Organization (WHO), one in six individuals faces infertility during their lifetime. Contributing factors include delayed parenthood, lifestyle habits, stress, obesity, and environmental pollutants. Fertility declines significantly in women after age 35, while male infertility is also rising due to reduced sperm quality. Governments and healthcare systems are acknowledging this challenge by supporting access to fertility treatments. In Europe, several countries offer full or partial reimbursement for IVF, while awareness initiatives by NGOs and health agencies are breaking social stigmas and encouraging treatment. Additionally, improved healthcare infrastructure and insurance access in developing nations are further enabling IVF adoption among a broader population base.

Key Market Challenges

High Cost of Treatment and Limited Accessibility

Despite growing demand, the high cost of IVF treatment remains a significant barrier, especially in low- and middle-income countries. IVF procedures often require substantial financial investment, with multiple cycles sometimes needed to achieve success. In many regions, fertility treatments are not fully covered by insurance, limiting access to those with financial means. For example, in the United States, IVF is frequently excluded from standard insurance plans, making it less accessible. In contrast, countries like Israel and certain parts of Europe provide public funding, resulting in higher uptake rates. The lack of universal coverage and inconsistent reimbursement structures continue to restrict broader adoption of IVF services.

Key Market Trends

Growing Acceptance of Fertility Preservation

Fertility preservation is emerging as a notable trend in the IVF market. Procedures such as egg, sperm, and embryo freezing are gaining popularity among individuals postponing parenthood for personal, career, or medical reasons. This trend is supported by healthcare providers and employers alike, with some companies now including fertility preservation as part of employee benefits. Additionally, fertility preservation is increasingly integrated into cancer care, with guidelines from medical bodies like ASCO recommending early discussions on fertility options before treatment. As public awareness and social acceptance of assisted reproduction continue to rise, the appeal of fertility preservation is expanding the IVF user base beyond traditional infertility patients, indicating strong long-term growth potential.

Key Market Players

• The Fertility Center of Las Vegas
• Overlake Reproductive Health
• Gennet City Fertility
• Zita West Clinic
• Fertility Plus Clinic
• Nova IVF Centre and Fertility Clinic
• Bloom IVF Centre
• Progenesis Fertility Center
• Medicana IVF Center
• Medical Park Hospitals
• ART Fertility Clinics

Report Scope:

In this report, the Global In-Vitro Fertilization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

In-Vitro Fertilization Market, By Technique:

• ICSI IVF
• Non-ICSI/ Traditional IVF

In-Vitro Fertilization Market, By Product:

• IVF Culture Media
• ICSI Machine
• IVF Incubators
• Cryo-System
• Others

In-Vitro Fertilization Market, By Egg Donor:

• Frozen non-donor
• Fresh non-donor
• Frozen Donor
• Fresh Donor

In-Vitro Fertilization Market, By Infertility:

• Male
• Female

In-Vitro Fertilization Market, By Application:

• Fertility Clinics
• Hospitals
• Others

In-Vitro Fertilization Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global In-Vitro Fertilization Market.

Available Customizations:

Global In-Vitro Fertilization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global In-Vitro Fertilization Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technique (ICSI IVF v/s Non-ICSI/ Traditional IVF)
  • 5.2.2. By Product (IVF Culture Media, ICSI Machine, IVF Incubators, Cryo-System, Others)
  • 5.2.3. By Egg Donor (Frozen Non-donor, Fresh Non-donor, Frozen Donor, Fresh Donor)
  • 5.2.4. By Infertility (Male v/s Female)
  • 5.2.5. By Application (Fertility Clinics, Hospitals, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Product Map

6. North America In-Vitro Fertilization Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technique
  • 6.2.2. By Product
  • 6.2.3. By Egg Donor
  • 6.2.4. By Infertility
  • 6.2.5. By Application
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States In-Vitro Fertilization Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technique
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Egg Donor
      • 6.3.1.2.4. By Infertility
      • 6.3.1.2.5. By Application
  • 6.3.2. Canada In-Vitro Fertilization Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technique
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Egg Donor
      • 6.3.2.2.4. By Infertility
      • 6.3.2.2.5. By Application
  • 6.3.3. Mexico In-Vitro Fertilization Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technique
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Egg Donor
      • 6.3.3.2.4. By Infertility
      • 6.3.3.2.5. By Application

7. Europe In-Vitro Fertilization Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technique
  • 7.2.2. By Product
  • 7.2.3. By Egg Donor
  • 7.2.4. By Infertility
  • 7.2.5. By Application
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France In-Vitro Fertilization Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technique
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Egg Donor
      • 7.3.1.2.4. By Infertility
      • 7.3.1.2.5. By Application
  • 7.3.2. Germany In-Vitro Fertilization Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technique
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Egg Donor
      • 7.3.2.2.4. By Infertility
      • 7.3.2.2.5. By Application
  • 7.3.3. United Kingdom In-Vitro Fertilization Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technique
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Egg Donor
      • 7.3.3.2.4. By Infertility
      • 7.3.3.2.5. By Application
  • 7.3.4. Italy In-Vitro Fertilization Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technique
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Egg Donor
      • 7.3.4.2.4. By Infertility
      • 7.3.4.2.5. By Application
  • 7.3.5. Spain In-Vitro Fertilization Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technique
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Egg Donor
      • 7.3.5.2.4. By Infertility
      • 7.3.5.2.5. By Application

8. Asia-Pacific In-Vitro Fertilization Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technique
  • 8.2.2. By Product
  • 8.2.3. By Egg Donor
  • 8.2.4. By Infertility
  • 8.2.5. By Application
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China In-Vitro Fertilization Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technique
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Egg Donor
      • 8.3.1.2.4. By Infertility
      • 8.3.1.2.5. By Application
  • 8.3.2. India In-Vitro Fertilization Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technique
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Egg Donor
      • 8.3.2.2.4. By Infertility
      • 8.3.2.2.5. By Application
  • 8.3.3. Japan In-Vitro Fertilization Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technique
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Egg Donor
      • 8.3.3.2.4. By Infertility
      • 8.3.3.2.5. By Application
  • 8.3.4. South Korea In-Vitro Fertilization Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technique
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Egg Donor
      • 8.3.4.2.4. By Infertility
      • 8.3.4.2.5. By Application
  • 8.3.5. Australia In-Vitro Fertilization Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technique
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Egg Donor
      • 8.3.5.2.4. By Infertility
      • 8.3.5.2.5. By Application

9. South America In-Vitro Fertilization Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technique
  • 9.2.2. By Product
  • 9.2.3. By Egg Donor
  • 9.2.4. By Infertility
  • 9.2.5. By Application
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil In-Vitro Fertilization Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technique
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Egg Donor
      • 9.3.1.2.4. By Infertility
      • 9.3.1.2.5. By Application
  • 9.3.2. Argentina In-Vitro Fertilization Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technique
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Egg Donor
      • 9.3.2.2.4. By Infertility
      • 9.3.2.2.5. By Application
  • 9.3.3. Colombia In-Vitro Fertilization Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technique
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Egg Donor
      • 9.3.3.2.4. By Infertility
      • 9.3.3.2.5. By Application

10. Middle East and Africa In-Vitro Fertilization Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technique
  • 10.2.2. By Product
  • 10.2.3. By Egg Donor
  • 10.2.4. By Infertility
  • 10.2.5. By Application
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa In-Vitro Fertilization Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technique
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Egg Donor
      • 10.3.1.2.4. By Infertility
      • 10.3.1.2.5. By Application
  • 10.3.2. Saudi Arabia In-Vitro Fertilization Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technique
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Egg Donor
      • 10.3.2.2.4. By Infertility
      • 10.3.2.2.5. By Application
  • 10.3.3. UAE In-Vitro Fertilization Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technique
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Egg Donor
      • 10.3.3.2.4. By Infertility
      • 10.3.3.2.5. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global In-Vitro Fertilization Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. The Fertility Center of Las Vegas
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Overlake Reproductive Health
• 15.3. Gennet City Fertility
• 15.4. Zita West Clinic
• 15.5. Fertility Plus Clinic
• 15.6. Nova IVF Centre and Fertility Clinic
• 15.7. Bloom IVF Centre
• 15.8. Progenesis Fertility Center
• 15.9. Medicana IVF Center
• 15.10. Medical Park Hospitals
• 15.11. ART Fertility Clinics

16. Strategic Recommendations

17. About Us & Disclaimer